Logo image of ALVAP.PA

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

Europe - EPA:ALVAP - FR0013419876 - Common Stock

4.3 EUR
-0.03 (-0.69%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, ALVAP scores 6 out of 10 in our fundamental rating. ALVAP was compared to 53 industry peers in the Specialty Retail industry. ALVAP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ALVAP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ALVAP had positive earnings in the past year.
ALVAP had a negative operating cash flow in the past year.
ALVAP had positive earnings in each of the past 5 years.
In the past 5 years ALVAP reported 4 times negative operating cash flow.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

The Return On Assets of ALVAP (9.80%) is better than 94.34% of its industry peers.
The Return On Equity of ALVAP (16.03%) is better than 84.91% of its industry peers.
The Return On Invested Capital of ALVAP (12.75%) is better than 90.57% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALVAP is significantly above the industry average of 8.43%.
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROIC 12.75%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ALVAP has a better Profit Margin (4.35%) than 81.13% of its industry peers.
In the last couple of years the Profit Margin of ALVAP has grown nicely.
ALVAP has a better Operating Margin (5.90%) than 79.25% of its industry peers.
In the last couple of years the Operating Margin of ALVAP has grown nicely.
The Gross Margin of ALVAP (23.53%) is worse than 67.92% of its industry peers.
ALVAP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALVAP is creating value.
ALVAP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALVAP has been increased compared to 5 years ago.
Compared to 1 year ago, ALVAP has an improved debt to assets ratio.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 4.60 indicates that ALVAP is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALVAP (4.60) is better than 92.45% of its industry peers.
ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
ALVAP has a better Debt to Equity ratio (0.21) than 88.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.6
ROIC/WACC1.88
WACC6.78%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 3.30 indicates that ALVAP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.30, ALVAP belongs to the top of the industry, outperforming 92.45% of the companies in the same industry.
ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
ALVAP has a Quick ratio of 1.76. This is amongst the best in the industry. ALVAP outperforms 88.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ALVAP have decreased strongly by -21.18% in the last year.
The Earnings Per Share has been growing by 97.48% on average over the past years. This is a very strong growth
ALVAP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.12%.
ALVAP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.89% yearly.
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

Based on estimates for the next years, ALVAP will show a decrease in Earnings Per Share. The EPS will decrease by -1.43% on average per year.
ALVAP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.11% yearly.
EPS Next Y-13.94%
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.31, the valuation of ALVAP can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 98.11% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.38. ALVAP is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 5.88, the valuation of ALVAP can be described as very cheap.
ALVAP's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALVAP is cheaper than 88.68% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALVAP to the average of the S&P500 Index (22.86), we can say ALVAP is valued rather cheaply.
Industry RankSector Rank
PE 5.31
Fwd PE 5.88
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ALVAP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALVAP is cheaper than 94.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.83
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ALVAP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%

More info and screens

6

5. Dividend

5.1 Amount

ALVAP has a Yearly Dividend Yield of 3.93%.
Compared to an average industry Dividend Yield of 3.39, ALVAP pays a better dividend. On top of this ALVAP pays more dividend than 88.68% of the companies listed in the same industry.
ALVAP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.93%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

17.39% of the earnings are spent on dividend by ALVAP. This is a low number and sustainable payout ratio.
DP17.39%
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

KUMULUS VAPE

EPA:ALVAP (9/19/2025, 7:00:00 PM)

4.3

-0.03 (-0.69%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap13.20M
Analysts86
Price Target7.91 (83.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.93%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.39%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.47%
EPS NY rev (3m)-16.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.8%
Revenue NY rev (3m)-7.69%
Valuation
Industry RankSector Rank
PE 5.31
Fwd PE 5.88
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.99
EV/EBITDA 2.83
EPS(TTM)0.81
EY18.84%
EPS(NY)0.73
Fwd EY17.01%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS19.77
BVpS5.37
TBVpS4.36
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROCE 17.84%
ROIC 12.75%
ROICexc 17.69%
ROICexgc 22.5%
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexcg growth 3Y1.55%
ROICexcg growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.6
F-Score3
WACC6.78%
ROIC/WACC1.88
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y-13.94%
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A
EBIT growth 1Y-24.16%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year20.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A